LNAINASDAQ Global Market·USD·Closed·Healthcare · Biotechnology
Lunai Bioworks Inc.
$0.29−$0.18 · −37.32%day vs prior
Mkt Cap · USD
1.34M
P/E · TTM
-0.4
Div Yield · ann
–
52-week
$0.23 – $13.28
at 1% of range
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
Loading chart data...
Signal state